- Home
- VCNX vs DATS Comparison
VCNX vs DATS Comparison
Compare VCNX & DATS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VCNX
- DATS
- Stock Information
- Founded
- VCNX 2001
- DATS 2014
- Country
- VCNX United States
- DATS United States
- Employees
- VCNX N/A
- DATS N/A
- Industry
- VCNX Biotechnology: Pharmaceutical Preparations
- DATS Computer Software: Prepackaged Software
- Sector
- VCNX Health Care
- DATS Technology
- Exchange
- VCNX Nasdaq
- DATS Nasdaq
- Market Cap
- VCNX 4.5M
- DATS 4.8M
- IPO Year
- VCNX N/A
- DATS 2021
- Fundamental
- Price
- VCNX $3.22
- DATS $2.26
- Analyst Decision
- VCNX
- DATS
- Analyst Count
- VCNX 0
- DATS 0
- Target Price
- VCNX N/A
- DATS N/A
- AVG Volume (30 Days)
- VCNX 167.3K
- DATS 3.5M
- Earning Date
- VCNX 11-29-2024
- DATS 11-26-2024
- Dividend Yield
- VCNX N/A
- DATS N/A
- EPS Growth
- VCNX N/A
- DATS N/A
- EPS
- VCNX N/A
- DATS N/A
- Revenue
- VCNX $388,000.00
- DATS $515.00
- Revenue This Year
- VCNX N/A
- DATS N/A
- Revenue Next Year
- VCNX N/A
- DATS N/A
- P/E Ratio
- VCNX N/A
- DATS N/A
- Revenue Growth
- VCNX N/A
- DATS N/A
- 52 Week Low
- VCNX $1.39
- DATS $1.01
- 52 Week High
- VCNX $13.02
- DATS $4.13
- Technical
- Relative Strength Index (RSI)
- VCNX 48.87
- DATS 62.96
- Support Level
- VCNX $2.87
- DATS $1.83
- Resistance Level
- VCNX $3.43
- DATS $2.54
- Average True Range (ATR)
- VCNX 0.53
- DATS 0.38
- MACD
- VCNX 0.05
- DATS 0.05
- Stochastic Oscillator
- VCNX 23.22
- DATS 39.64
About VCNX Vaccinex Inc.
Vaccinex Inc is pioneering a differentiated approach to treating cancer and slowly progressive neurodegenerative diseases through the inhibition of semaphorin 4D (SEMA4D). The company's lead drug candidate, pepinemab, blocks SEMA4D, a potent biological effector that it believes prevents immune infiltration into tumors and triggers inflammation in chronic diseases of the brain. Pepinemab is being evaluated in a Phase 1b/2 study in recurrent or metastatic head and neck cancer and in a Phase 1/2a study in Alzheimer's Disease, with ongoing exploration of potential Phase 3 development in Huntington's disease. The firm has also developed a proprietary drug discovery platform, ActivMAb.
About DATS DatChat Inc.
DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts, even after they are sent.